Category English

IP-Watch Guide To 2017 World Health Assembly: Election, Budget, Antibiotics, Cancer, R&D And More

In a few days, the 70th World Health Assembly will open its doors in Geneva with a marathon agenda, and over 4,000 registered delegates. The election of a new director general, the approval of the budget for the next biennium (2018/2019) are set to capture the attention of member states. However, many other subjects require their consideration, such as a resolution on cancer treatment costs, research and development for epidemic diseases, for new antibiotics, for medicines affecting primarily poor populations, access to medicines, and the influenza pandemic preparedness framework.

How The CIA WikiLeaks Disclosure Diverts Attention From Big Picture

The WikiLeaks publication of hacking tools and malware the CIA has allegedly used continues to stir the ire and fear of those concerned about the possible risk of the US government’s backdoor access to private data. But WikiLeaks' publication of alleged CIA-created malware instructions, which the CIA has not confirmed as authentic, diverts attention away from how numerous other state-sponsored agents are aggressively seeking to steal intellectual property and other data, security experts say.

Longest, Biggest World Health Assembly Ever Set To Open With Election, Budget Topping Agenda

The 70th World Health Assembly opening in a few days is the WHA of superlatives, according to a World Health Organization’s official. It is the longest assembly ever, with nine days of meeting, the largest number delegates, of agenda items, and of documents. It is also when the new WHO new director general will be elected, and when the WHO next budget is expected to be approved.

WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines

The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants.

WHO Studies On Local Pharma Production Provide Key Contrasts Between China, India

Two new studies published by the World Health Organization provide insight on the production of pharmaceutical products in India and China. According to the studies, China has a substantial local pharmaceutical manufacturing sector which the Chinese government is closely linking to its policy objective of universal health care. India, the main global provider of generic medicines is not pursuing a comparable focus on universal health care. India is increasingly faced with Chinese pharmaceutical sector competition, with China being its main provider of commoditized active pharmaceutical ingredients (APIs).

Access Treaty for Visually Impaired Readers (Finally) Steps Forward On EU Ratification

After prevaricating for about three years, the European Union now seems to be about to ratify a treaty lifting copyright across borders for books in special format for visually impaired people. The European Blind Union saluted the agreement as great news for millions of people with visual disabilities but warned that a provision allowing EU members to impose economic compensation on organisations representing blind persons and libraries could run counter to the benefit of the treaty.